Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Brain Canada | OTHER |
| Sunnybrook Health Sciences Centre | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The primary study aims are to determine the clinical, behavioural and social predictors of SMI development in youth, and to investigate whether neuroimaging can distinguish youth who will develop SMI from those who will not.
The study's secondary aims are to examine the proportions of the cohort that make transitions between the different clinical stages of risk, and to determine the proportions that have poor outcomes, defined as ongoing or increased symptoms, secondary substance misuse, poor social or role functioning, i.e., non-participation in education, or employment, and new self-harm.
Investigators will study a cohort of 240 youth (aged 14-25, male and female) that includes youth with early mood symptoms or sub-threshold psychotic symptoms (symptomatic group; n=160), youth at risk due to a family history of a SMI (family high risk (FHR); n=40), and healthy controls (HC; n=40). From this cohort, clinical, social and cognitive data, as well as imaging data will be gathered to create a multi-layered "snapshot" of these individuals and provide full-level characterization. Investigators will use the full range of clinical and imaging data generated from this cohort to develop novel prediction algorithms incorporating key variables that predict the development of SMI.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Diagnosis of serious mental illness (SMI) | The Structured Clinical Interview for DSM-IV Disorders (SCID-1) will be used to determine the presence of any Axis I disorder | 2 year |
| Measure | Description | Time Frame |
|---|---|---|
| Level of risk on a Clinical Staging Model for Mental Health Disorders based on the Scale of Prodromal Symptoms (SOPS) | Level of risk will be defined based on a Clinical Staging Model for Mental Health Disorders (Hickie IB, Scott EM, Hermens DF et al. Applying clinical staging to young people who present for mental health care. Early Interv Psychiatry 2012.) Individuals will be assigned a stage based on their scores on the SOPS. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Young people aged 12-25 who report 1 of the following:
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jean Addington | University of Calgary | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mathison Centre for Research and Education, University of Calgary | Calgary | Alberta | T2N4Z6 | Canada | ||
Not provided
| ID | Term |
|---|---|
| D011618 | Psychotic Disorders |
| D003865 | Depressive Disorder, Major |
| D001714 | Bipolar Disorder |
| ID | Term |
|---|---|
| D019967 | Schizophrenia Spectrum and Other Psychotic Disorders |
| D001523 | Mental Disorders |
| D003866 | Depressive Disorder |
| D019964 | Mood Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Blood samples
| 2 year |
| Level of risk on a Clinical Staging Model for Mental Health Disorders based on the Calgary Depression Scale for Schizophrenia (CDSS). | Level of risk will be defined based on a Clinical Staging Model for Mental Health Disorders (Hickie IB, Scott EM, Hermens DF et al. Applying clinical staging to young people who present for mental health care. Early Interv Psychiatry 2012.) Individuals will be assigned a stage based on scores on the CDSS. | 2 year |
| Level of risk on a Clinical Staging Model for Mental Health Disorders based on the Young Mania Scale | Level of risk will be defined based on a Clinical Staging Model for Mental Health Disorders (Hickie IB, Scott EM, Hermens DF et al. Applying clinical staging to young people who present for mental health care. Early Interv Psychiatry 2012.) Individuals will be assigned a stage based on their scores on the Young Mania Scale. | 2 year |
| Clinical symptoms on the Young Mania Scale. | Individuals' clinical symptoms will be measured using scores on the Young Mania Scale. | 2 year |
| Clinical symptoms on the SOPS. | Individuals' clinical symptoms will be measured using scores on positive symptoms on the SOPS. | 2 year |
| Clinical symptoms on the CDSS. | Individuals' clinical symptoms of depression will be measured using scores on the CDSS. | 2 year |
| Functioning | Functioning will be assessed using Global Functioning (Social & Role) | 2 year |
| Structural brain changes | MRI images will be examined for changes in structural data using regional grey matter intensity. | 2 year |
| Structural Brain changes | MRI images will be examined for changes in structural data using white matter integrity | 2 year |
| Functional Brain changes | MRI images will be examined for changes in functional data using resting-state connectivity among brain regions of interest | 2 year |
| Changes in cognition | Cognition is assessed using the MATRICS Cognitive Battery | 2 year |
| Sunnybrook Health Sciences Centre |
| Toronto |
| Ontario |
| M4N 3M5 |
| Canada |
| D000068105 | Bipolar and Related Disorders |